APA (7th ed.) Citation

BCY, T., S, B., P, S., G, H., N, P., SJ, C., . . . MP, M. (2023). CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy. Oncoimmunology, 12(1), 2238506. https://doi.org/10.1080/2162402X.2023.2238506

Chicago Style (17th ed.) Citation

BCY, Tse, et al. "CD11c+ and IRF8+ Cell Densities in Rectal Cancer Biopsies Predict Outcomes of Neoadjuvant Chemoradiotherapy." Oncoimmunology 12, no. 1 (2023): 2238506. https://doi.org/10.1080/2162402X.2023.2238506.

MLA (9th ed.) Citation

BCY, Tse, et al. "CD11c+ and IRF8+ Cell Densities in Rectal Cancer Biopsies Predict Outcomes of Neoadjuvant Chemoradiotherapy." Oncoimmunology, vol. 12, no. 1, 2023, p. 2238506, https://doi.org/10.1080/2162402X.2023.2238506.